Today, the XIV All‑Russian Scientific and Practical Conference “Safety and Efficacy of ...
Today, the XIV All‑Russian Scientific and Practical Conference “Safety and Efficacy of Antithrombotic Therapy: A Patient‑Centred Approach” came to a close. The conference was organised by the staff of the Department of Clinical Pharmacology and Pharmacotherapy at Northern State Medical University (NSMU), and was held at the First City Clinical Hospital named after E. E. Volosevich. 🔹The participants included faculty members, students, and residents of our university, as well as doctors and healthcare professionals from the Arkhangelsk Region and many other regions of Russia. 🔹The event served as the final milestone in a series of activities dedicated to World Thrombosis Day in Russia, and demonstrated that a serious topic can be explored not only through formulas but also through meaningful insights. 🔹The conference got off to a very warm start. The organisers added a creative touch to the strictly scientific format: before the official proceedings began, the hall hosted a fashion show featuring a new collection by an Arkhangelsk designer, accompanied by live jazz improvisation performed by young musicians—students of a well‑known jazz singer. Participants were welcomed by Nadezhda Alexandrovna Bylova, Acting Rector of NSMU: “I am very glad that today specialists from various fields have gathered together in the hall and online. Issues of thrombosis and hemostasis are relevant for doctors of any specialty: this is knowledge that every physician should possess. Continuing medical education is not just a catchphrase—these important pieces of information must be updated regularly. It is especially valuable that the study of this problem involves not only colleagues from fundamental and clinical fields but also schoolchildren—through creative contests. This helps to foster a conscious attitude towards the topic from an early age.” 🔹The conference programme kept the audience engaged, covering everything from the latest developments in the antithrombotic field to pressing interdisciplinary topics. Participants discussed domestic technologies for molecular genetic analysis, the fine line between overdiagnosis and real clinical risks in hemostasis genetics, and the role of homocysteine in predicting the severity of ischemic stroke. A particular stir was caused by the report on microplastics as a new potential risk factor for thrombus formation—from experimental data to clinical reality. 🔹On the second day, theory met practice: a masterclass on interpreting molecular genetic data using fragment analysis was held. It was conducted by Yakov Igorevich Alekseev, a Russian scientist and specialist in biotechnology and molecular genetics. Participants worked through real‑life cases, learning to see the clinical picture behind the numbers and not to miss the key points. The conference demonstrated that combating pathological thrombosis is not a narrow specialty but a shared responsibility. Bringing together fundamental science, clinical practice, education, and even outreach formats offers a chance not just to treat but to prevent. And it is precisely this multidimensional approach—attentive to details and to the person—that is becoming the standard today.